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A body mass index (BMI)X25 kg/m2 increases the risk for
long-term renal damage, possibly by renal hemodynamic
factors. As epidemiological studies suggest interaction of BMI
and sodium intake, we studied the combined effects of
sodium intake and BMI on renal hemodynamics. Glomerular
filtration rate (GFR) and effective renal plasma flow (ERPF)
were measured in 95 healthy men (median age 23 years (95%
confidence interval: 22–24), BMI: 23.072.5 kg/m2) on low
(50 mmol Naþ , LS) and high (200 mmol Naþ , HS) sodium
intake. Mean GFR and ERPF significantly increased by the
change to HS (both Po0.001). During HS but not LS, GFR and
filtration fraction (FF) positively correlated with BMI (R¼ 0.32
and R¼ 0.28, respectively, both Po0.01). Consequently, BMI
correlated with the sodium-induced changes in GFR (R¼ 0.30;
Po0.01) and FF (R¼ 0,23; Po0.05). The effects of HS on
GFR and FF were significantly different for BMIX25 versus
o25 kg/m2, namely 7.8712.3 versus 16.1713.1 ml/min
(Po0.05) and 0.172.2 and 1.172.3% (Po0.05). FF was
significantly higher in BMIX25 versus o25 kg/m2, (22.672.9
versus 24.672.4%, Po0.05) only during HS. ERPF was not
related to BMI. Urinary albumin excretion was increased
by HS from 6.0 (5.4–6.7) to 7.6 (6.9–8.9). Results were
essentially similar after excluding the only two subjects
with BMI430 kg/m2. BMI is a determinant of the renal
hemodynamic response to HS in healthy men, and of GFR
and FF during HS, but not during LS. Consequently, HS
elicited a hyperfiltration pattern in subjects with a
BMIX25 kg/m2 that was absent during LS. Future studies
should elucidate whether LS or diuretics can ameliorate the
long-term renal risks of weight excess.
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Excess body weight is a risk factor for loss of kidney function
in different renal disorders.1–3 Recent studies showed that a
body mass index (BMI) above 25 kg/m2 in young adults is
associated with an increased risk for end-stage renal disease
on long-term follow-up, not only in subjects with a specific
renal parenchymal disorder, hypertension, or diabetes, but
also without those conditions.4–8 The mechanisms underlying
the predisposition to renal damage associated with a higher
BMI are incompletely understood. In overt obesity, the
mechanisms are assumed to involve hypertension,9 insulin
resistance,10 as well as an unfavorable hemodynamic profile
with renal hyperperfusion and hyperfiltration.9,11–13 As a
higher BMI is associated with a renal hyperfiltration profile
also in healthy subjects without overt obesity, renal hemo-
dynamics could be relevant in the renal effects of an extent of
weight excess that does not amount to overt obesity yet.12
In population studies, a high BMI was strongly associated
with a higher urinary albumin excretion (UAE).14,15 Interest-
ingly, an interaction was observed between high dietary sodium
intake (estimated by urinary sodium excretion) and excess
body weight as risk factors for UAE.15 The renal mechanisms
underlying this interaction would be of interest. Studies in
essential hypertensive subjects have shown that a high sodium
(HS) intake can elicit albuminuria,16 with an unfavorable renal
hemodynamic profile.17 This raises the hypothesis that renal
hemodynamic factors are involved in the interaction between
sodium intake and BMI on UAE. Whereas the renal response to
HS has been addressed in various populations,12,14,15,17–21 the
effect of BMI on the renal hemodynamic response to a HS
intake has not been established so far.
Therefore, in the present study we investigated the influence
of BMI on the renal hemodynamic response to a shift in
sodium intake in healthy young male adults. They were
studied during a period of low sodium (LS) (50 mmol/day)
and an HS (200 mmol/day) intake, that is, a sodium intake
reflecting the lower and upper boundaries of a normal intake.
RESULTS
Median age was 23 years (95% confidence interval: 22–24)
and mean BMI 23.072.5 kg/m2. The distribution of BMI
values in our population is shown in Figure 1. The
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distribution of BMI was somewhat skewed, with overt obe-
sity (BMIX30 kg/m2) in two subjects and overweight
(BMIX25 kg/m2) in 16 out of 95 subjects.
Subject characteristics on LS versus HS diet are given in
Table 1. It shows that the differences in diet resulted in the
expected differences in sodium excretion (UNa24). HS intake
caused a significant increase in body weight, consistent with a
positive volume balance. Potassium excretion (UK24) was
similar during both diet periods. Blood pressure was slightly
higher during HS (P¼ 0.06). In the study group as a whole,
there were significant increases in effective renal plasma flow
(ERPF) and glomerular filtration rate (GFR) in response to a
change from LS to an HS diet, without a change in filtration
fraction (FF). Fasting plasma glucose and insulin levels were
in the non-diabetic range on both diets, with no differences
between LS and HS intake. The UAE was below the threshold
for detection in 23 and 34 out of 95 subjects on LS and HS
intake, respectively. As a consequence, paired comparison of
UAE between the diets was possible in only 53 subjects. In
these subjects, UAE was significantly higher on HS intake.
Active plasma renin concentration and aldosterone levels
were significantly higher during the LS diet.
On univariate analysis, BMI was significantly associated
with GFR and FF (Figure 2, middle panels) during HS intake
but not during LS (Figure 2, upper panels). As a con-
sequence, BMI was positively and significantly correlated with
sodium-induced changes in GFR and FF (Figure 2, lower
panels).
The impact of a BMIX25 kg/m2 on the renal hemo-
dynamic response to HS is shown in Table 2, providing mean
values of blood pressure and renal hemodynamics by a break-
up by a BMIo or X25 kg/m2. First, it shows that mean
arterial pressure and ERPF, and their sodium-induced
changes were not affected by BMI on either sodium intake.
Second, during LS intake GFR was similar for both groups as
well. However, the change in GFR (DGFR) elicited by the rise
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Figure 1 | Distribution of BMI.
Table 1 | Urinary electrolytes, body weight, blood pressure,
renal hemodynamics, and metabolic parameters during LS
versus HS intake
Sodium intake
50 mmol/24 h 200 mmol/24 h
P-value for
difference
UNa24 (mmol/24 h) 39727 251777 o0.001
Body weight (kg) 78.7710,3 80.0710.3 o0.001
UK24 (mmol/24 h) 83732 82728 NS
MAP (mm Hg) 8777 8877 0.06
ERPF (ml/min) 5637101 6027115 o0.001
GFR (ml/min) 127718 136720 o0.001
FF (%) 22.873.0 23.072.9 NS
Glucose (mmol/l) 4.770.7 4.670.6 NS
Insulin (mE/l) 8.9 (8.2–10.0) 9.0 (7.6–10.0) NS
UAE (mg/24 h)* 6.0 (5.4–6.7) 7.6 (6.9–8.9) o0.01
APRC (ng ang-I/ml/h) 5.8 (5.2–7.1) 2.2 (1.8–2.6) o0.001
Aldosterone (ng/l) 130 (112–138) 40 (32–46) o0.001
APRC, active plasma renin concentration; ERPF, effective renal plasma flow; FF,
filtration fraction; GFR, glomerular filtration rate; HS, high sodium; LS, low sodium;
MAP, mean arterial pressure; NS, not significant; UAE, urinary albumin excretion;
UNa24, 24-h urinary Na
+ excretion; UK24, 24-h urinary K
+ excretion.
Data are expressed as mean (7s.d.) or median (95% CI for the median).
*LS: n=72, HS: n=61, paired test in 53 subjects.
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Figure 2 | Scatterplot describing the correlation between BMI and
GFR during LS and HS and the sodium-induced change in GFR
(DGFR): left panels. Correlations between BMI and FF during LS and
HS, and sodium-induced change in FF (WFF): right panels.
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in sodium intake was significantly larger in group with
BMIX25 kg/m2 (Po0.05). FF was not different during LS
intake either, but the response of FF to the change in sodium
intake was significantly different between subjects with a
BMIo25 and those with a BMIX25 kg/m2, that is,
0.172.2 versus 1.172.3, respectively (Po0.05). As a
consequence, during HS intake FF was significantly higher
in subjects with a BMIX25 kg/m2 than in those with a lower
BMI (Po0.05). For GFR, the difference between subjects
with BMIX25 versus o25 kg/m2 during HS did not quite
reach statistical significance. No impact of BMI was found on
glucose, insulin, active plasma renin concentration, and
aldosterone and their sodium-induced changes (data not
shown).
As described in our Materials and Methods section, the
analysis was also performed for renal hemodynamics indexed
for height, with results similar to the non-indexed data.
Briefly, the differences in GFR on HS intake were also present
for GFR expressed per meter of height, being 7279 and
77711 ml/min/m for BMI below and above 25 kg/m2,
respectively (P¼ 0.06). Obviously, the analysis on BMI-
related effects on the sodium-induced changes in GFR and FF
remained the same. Finally, we repeated our analyses after
exclusion of the two subjects with overt obesity: this did not
essentially alter the results.
DISCUSSION
This study demonstrates that the renal hemodynamic
response to a shift in sodium intake is correlated to BMI in
healthy young men, with larger increases in GFR and FF in
subjects with a higher BMI. As a consequence, a relationship
between higher BMI and higher GFR and FF was present only
during high, but not during LS intake. When analyzed by a
break-up by BMIX25 kg/m2, the renal hemodynamic
response to HS was significantly larger in subjects with
BMIX25 kg/m2, and consequently, a hyperfiltration pattern
was observed in these subjects during HS intake only. These
results were unaltered after exclusion of the only two subjects
with overt obesity, and thus appear to pertain to the
overweight range.
The impact of higher BMI as a risk factor for renal damage
is increasingly recognized. Earlier studies reported deleterious
long-term renal effect of overt obesity in diverse renal
conditions.1–3 More recent large epidemiological studies
confirmed the increased risk for long-term renal damage in
overt obesity, that is, a BMI over 30 kg/m2, and moreover
demonstrated that less severe weight excess, that is, a
BMIX25 kg/m2 was associated with a significantly increased
long-term risk for end-stage renal disease as well.8,9 This risk
was apparent for subjects with renal parenchymal disease,
hypertension, or diabetes, but also in the absence of these
conditions.
These data prompt for elucidating the underlying
mechanisms that predispose to long-term renal damage in
subjects with a higher BMI. Studies in overt obesity support a
role for renal hemodynamic factors, with hyperfiltration in
morbidly obese and obese subjects. These are usually
associated with hypertension and impaired glucose toler-
ance9,10,12 but have also been observed independently of these
factors.14 Moreover, BMI-associated hyperfiltration has been
reported in the absence of overt obesity, diabetes, or
hypertension.11 Together, these data point toward an
independent effect of BMI in the overweight range on renal
hemodynamics.
Our current study is in line with these prior data. It
provides additional insights by demonstrating that a shift in
sodium intake modifies the association between BMI and
renal hemodynamics by eliciting the BMI-associated hyper-
filtration pattern during HS, and ameliorating it during
sodium restriction in the same subjects. If indeed renal
hemodynamic factors contribute to the long-term risk
conferred by a higher BMI, our data might implicate that
sodium restriction could exert a beneficial effect on long-
term renal risk, but obviously long-term studies would be
required to substantiate such an assumption. At any rate, we
took care to study a range of sodium intake that bears clinical
relevance, as neither the HS intake, nor the LS intake was
extreme.
What could be the mechanisms underlying the effect of
BMI on the renal response to HS? First, it should be noted
that our study was not designed to address mechanisms, as
we performed no intervention in candidate pathways. The
effect of HS on renal hemodynamics in our subjects with a
higher BMI showed a remarkable parallel to studies by
ourselves and others in sodium-sensitive hypertensives,
demonstrating a change toward hyperfiltration elicited by
HS.17,19,22,23 Inappropriate activity of the renin–angiotensin
system (RAS) during HS was shown to be involved in this
unfavorable renal hemodynamic profile.24 In obesity, several
Table 2 | Renal function parameters and urinary electrolytes
during LS versus HS intake. Break-up according to
BMIX25.0 kg/m2
BMIo25 kg/m2
n=77
BMIX25 kg/m2
n=18
P-value for
difference
BMI (kg/m2) 22.171.4 26.972.4 —
MAP LS (mm Hg) 8676 8879 NS
MAP HS (mm Hg) 8777 9177 NS
D MAP (mm Hg) 175 276 NS
ERPF LS (ml/min) 5687106 545771 NS
ERPF HS (ml/min) 6067122 584776 NS
D ERPF (ml/min) 38764 39756 NS
GFR LS (ml/min) 127718 127717 NS
GFR HS (ml/min) 134719 143723 0.09
D GFR (ml/min) 7.8712.3 16.1713.1 o0.05
FF LS (%) 22.673.0 23.572.7 NS
FF HS (%) 22.672.9 24.672.4 o0.05
D FF (%) 0.172.2 1.172.3 o0.05
UNa24 LS (mmol/24 h) 40728 34718 NS
UNa24 HS (mmol/24 h) 250778 255775 NS
D UNa24 HS (mmol/24 h) 210782 222786 NS
BMI, body mass index; ERPF, effective renal plasma flow; FF, filtration fraction; GFR,
glomerular filtration rate; HS, high sodium diet (200 mmol/24-h); LS, low sodium diet
(50 mmol/24-h); MAP, mean arterial pressure; NS, not significant (P40.05); UNa24,
24-h urinary Na+ excretion.
Data are expressed as mean7s.d.
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lines of evidence support inappropriate intrarenal RAS
activity as well. In an animal model, Barton et al.25 found
increased intrarenal angiotensin-converting enzyme asso-
ciated with obesity, mediated by endothelin. In human,
interestingly, in follow-up on an earlier observation on the
renal response to RAS blockade and BMI in type II
diabetes,26 recently a strong correlation was reported between
a higher BMI and a larger renal vasodilator response to
angiotensin-converting enzyme of angiotensin receptor
blocker in healthy subjects on an HS intake.27 The association
was best described by a quadratic fit, with a steeper
relationship between vasodilator response to RAS blockade
and BMI in the obese and morbidly obese range. However,
also in subjects with a BMI 25–30 kg/m2, a renal vasodilator
response to RAS blockade was apparent, whereas this was
nonsignificant in lean subjects. These data in the overweight
range can be considered in line with our present data,
suggesting increased angiotensin-dependent control of renal
hemodynamics in overweight as compared to lean subjects.
Such effects of angiotensin could well be implicated in our
findings. If so, our findings suggest that inappropriate RAS
activity is apparently relevant to renal hemodynamics during
HS, that is, a condition where RAS activity should normally
be suppressed, but not during LS, where it is appropriate for
the RAS to be activated. In our study, BMI had no effect on
circulating parameters of RAS activity, which is in line with
the above studies. However, circulating parameters do not
adequately reflect intrarenal RAS activity. Whereas inap-
propriate RAS activity thus may be involved in our findings,
other neuro-humoral pathways such as the renal sympathetic
nervous system28 and endothelin29 could also be involved.
Several lines of evidence suggest a link between obesity,
insulin resistance, and RAS activity. A higher BMI is
associated with increasing insulin resistance.30,31 Hepatic
production of angiotensinogen is enhanced by higher plasma
insulin levels.32,33 In addition, increased insulin resistance
was reported during HS in rats34 and in healthy normo-
tensive males.35 Thus, the combination of overweight and HS
could induce inappropriate RAS activation by elevated
insulin levels. In contrast to prior reports in healthy
subjects36 and in type II diabetes,37 however, in our popu-
lation no differences in insulin between LS and HS could
be demonstrated, which renders this possible mechanism
less likely.
For our study, we selected young healthy volunteers, to
avoid the effects of subclinical renal target organ damage or
of hypertension on the renal response to HS. However, by
these selection criteria, our population might well include
subjects that will develop hypertension at middle age, be it in
association with sodium sensitivity or not, with the
corresponding renal hemodynamic risk profile. It would be
of interest to see whether the current renal response to
sodium predicts hypertension on long-term follow-up, but
attempts to identify individuals prone to develop hyperten-
sion based on the current data would be too speculative. At
any rate, the renal response to HS in the present study was
not associated with the sodium sensitivity of blood pressure
in these normotensive individuals.
What are the clinical implications of our findings? The
impact of excess sodium intake as a renal risk factor was
emphasized recently.38,39 Our data are in line with the alleged
role of excess sodium as a renal risk factor, and provide a
possible mechanism underlying the interaction between BMI
and HS on renal risk that was observed in epidemiological
studies. Our subjects were young and the observed effects of
BMI were apparently not explained by overt obesity. In young
adults, overt obesity is still relatively rare, and overweight is
much more frequent, as also shown by the distribution of
BMI in our population. As a BMIX25 kg/m2 is already
associated with an increased long-term risk for end-stage
renal disease, on a population basis the long-term renal
impact of the interaction between sodium status and BMI
can potentially be substantial, but longitudinal data would be
needed to support this assumption.
As a possible marker of subclinical renal risk, we measured
UAE. As expected, this was normal in all subjects, and in fact
it was below the level of detection in many cases, so in only
53 subjects we were able to compare UAE on LS versus HS.
These restrictions taken in mind, it is nevertheless remarkable
that UAE was higher on HS. This observation has not been
made in healthy subjects before, but is in line with prior
cross-sectional observations in epidemiological studies15 and
with studies in type II diabetics with microalbuminuria.40 We
did not detect an interaction between BMI and sodium
intake on UAE, but obviously the power of our study to
detect such an interaction was insufficient.
A limitation of our study is that that we measured renal
hemodynamics after only 1 week of diet. Whereas this time
frame is sufficient to restore sodium balance after a change of
diet, it is not sure whether renal hemodynamics remain
similar during long-term changes in sodium status. For
between-individual comparison, renal hemodynamics are
usually expressed per 1.73 m2 body surface area. However, a
rise in BMI elicits a rise in body surface area. Hence, indexing
for body surface area will bias analyses that address effects
of BMI.41,42 Therefore, we present the non-indexed data,
but additionally repeated the analyses after indexing for
height, with similar results. Moreover, our data on the
individual sodium-induced changes in renal hemodynamics
are independent of indexing, and thus are robust against
assumptions about the appropriate adjustment.
This is the first study to show that BMI is an important
determinant of the renal hemodynamic adaptation to an HS
intake in young healthy men. Moreover, our data show that
HS elicits a hyperfiltration pattern in subjects with a
BMIX25 kg/m2, which is absent during LS. These data
suggest that renal hemodynamic factors may be involved in
the interaction between BMI and sodium intake on the
kidney that was observed in prior epidemiological studies,
and prompt to explore the role of sodium intake as a
modifier of the long-term renal risk associated with weight
excess.15,38
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MATERIALS AND METHODS
Subjects
The study population consisted of 95 healthy normotensive men not
selected for BMI. Normal blood pressure was confirmed by repeated
non-invasive automatic blood pressure assessment (Dinamap) and
defined as systolic blood pressureo140 mm Hg and diastolic blood
pressureo90 mm Hg. The study was approved by the local medical
ethics committee, in accord with the Declaration of Helsinki
Principles, and all participants gave written informed consent. All
medical histories were without significant disease, and results of
physical examination were unremarkable.
Study protocol
Subjects were studied at the end of two different 7-day periods,
during which they used a LS diet (50 mmol Naþ /day) and an HS
diet (200 mmol Naþ /day), respectively. Potassium intake was
standardized at 80 mmol/day. Otherwise, the subjects continued
their usual food habits. For assessment of dietary compliance and
sodium balance, 24 h urine was collected at day 4 and day 6 during
each period. During both periods, the subjects were ambulant and
continued their normal activities.
At day 7 of both study periods, the subjects reported at the
research unit at 0800 hours, after having abstained from food and
alcohol overnight. Height and body weight were measured at the
start of this day and BMI was calculated as the ratio of body weight
(kg) and the square of height (m).
During the study day, subjects remained in a semi-supine
position except during voiding. One intravenous cannula was
inserted in each forearm. One was used for infusion of tracers and
the other for infusion of fluids and blood sample withdrawal. Blood
was collected for fasting glucose and insulin determination. At 1100
hours, blood was withdrawn for determination of active plasma
renin concentration and aldosterone. Sodium intake during the day
was adjusted according to the actual diet in the concerning diet
period. To ensure sufficient urine output, 250 ml of 5% glucose
solution was administered in the right antecubital vein and subjects
were provided with 250 ml of oral fluids every hour. After a 2 h run-
in period, GFR and ERPF were measured as the clearances of
constantly infused 125I-Iothalamate and 131I-Hippuran, respectively.
In this set-up, GFR is measured as the urinary clearance of 125I-
Iothalamate, and corrected for voiding errors by the ratio of plasma
to urinary clearance of 131I-Hippuran, as described in more detail
previously.43 The coefficient of variation of this method is 2.5% for
GFR and 5% for ERPF. FF was calculated as the ratio of GFR and
ERPF and expressed as percentage (%). Blood pressure was assessed
with an automatic device (Dinamap) at 15 min intervals. Mean
arterial pressure was calculated as diastolic pressure plus one-third
of the pulse pressure.
Chemical analysis of urine and blood samples
Urinary concentrations of sodium and potassium were measured by
standard auto-analyser technique (MEGA, Merck, Darmstadt,
Germany). UAE was determined by nephelometry with a threshold
of 2.3 mg/l (Dade Behring Diagnostic, Marburg, Germany). Insulin
was determined on an AxSym with a threshold of 1.0mU/Ml and
intra-assay and inter-assay coefficients of variation of 2.6 and 4.3%,
respectively (Abbott BV, Amstelveen, The Netherlands). Active
plasma renin concentration was determined in terms of angiotensin
I generation using a radioimmunoassay.44 Aldosterone was mea-
sured with a commercially available radioimmunoassay kit (Diag-
nostic Products Corporation, Los Angeles, CA, USA). Plasma
glucose was determined by glucose-oxidase method (YSI 2300 Stat
plus, Yellow Springs, OH, USA).
Data analysis
Data were analyzed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA).
Data with a normal distribution are expressed as mean7s.d. Non-
parametric data are given as median (95% confidence interval).
Simple Pearson’s parametric correlation was used for continuous
analysis of the influence of BMI on renal hemodynamics. The
average BMI over both conditions of sodium intake was used for
analysis. For the total group, the effect of the change in sodium
intake was assessed by a paired sample t-test for parametric data and
a Wilcoxon’s signed rank test for non-parametric data. Furthermore,
data were analyzed according to the break-up by BMIX25 kg/m2,
that is, the usual cutoff for overweight, using a Student’s t-test to
compare the groups with BMIX25 and o25 kg/m2.
Data on renal hemodynamics were analyzed both as crude values
and after normalization for height. We refrained from normalization
by body surface area as such normalization by definition will
confound analyses for BMI-related effects, and for this reason,
normalization by height has been recommended.41,45 In this paper,
we present the analysis as carried out on crude data, but additionally
we performed the same analyses after indexing for height, with
similar outcomes. A two-sided P-value o0.05 was considered to be
significant.
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